SHAREHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)				3 Months Ended			4 Months Ended	9 Months Ended
	May 15, 2022	Feb. 14, 2022	Jan. 13, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 02, 2022	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized				200,000,000			200,000,000	200,000,000			200,000,000
Common stock, par value				$ 0.0001			$ 0.0001	$ 0.0001			$ 0.0001
Preferred stock, shares authorized				20,000,000			20,000,000	20,000,000			20,000,000
Preferred stock, par value				$ 0.0001			$ 0.0001	$ 0.0001			$ 0.0001
Issuance of common shares for cash, shares			96,000
Share issued price per share			$ 2.50
Proceeds from issuance of private placement			$ 220,572
Proceeds from issuance initial public offering								$ 13,602,554
Debt Issuance Costs, Net											$ 300,460
Deferred cost recognized											$ 178,847
Common stock issued from exercise of stock option		273,489
Common stock issued from exercise of stock option, shares		$ 16				$ 16
Stock issued during the period restricted shares	83,333
Stock repurchase value				$ 2,163,238	$ 1,336,762
Common stock, shares issued				18,999,276			18,999,276	18,999,276			15,819,943
Common stock, shares outstanding				17,649,886			17,649,886	17,649,886			15,546,454
Preferred stock, shares issued				0			0	0			0
Preferred stock, shares outstanding				0			0	0			0
2022 Share Repurchase Program [Member]
Subsidiary, Sale of Stock [Line Items]
Share issued price per share				$ 2.59			$ 2.59	$ 2.59
Stock repurchase program authorized amount										$ 3,500,000
Stock repurchase shares							1,349,390
Stock repurchase value							$ 3,500,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common shares for cash, shares		3,000,000
Share Price		$ 5.00
Proceeds from issuance initial public offering		$ 13,724,167
Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common shares for cash, shares			30,000